EyePoint, Inc. (EYPT)

↓ Download CSV

CIK 0001314102 · Nasdaq · Laboratory Analytical Instruments

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, EyePoint, Inc. reported revenue of $31.37M, down 27.5% from the prior year. The company ran a net loss, with a net margin of -739.4%. It held $364.00M in total assets against $57.88M in total liabilities.

Key ratios (FY2025)

-776.0%
Operating margin
-739.4%
Net margin
-75.8%
Return on equity
-27.5%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$31.37M$43.27M$46.02M$41.40M$36.94M$34.44M$20.36M$4.57M$7.54M$1.62M
Operating Income-$243.43M-$145.85M-$75.07M-$99.64M-$55.28M-$37.29M-$47.86M-$39.02M-$18.58M-$21.77M
Net Income-$231.96M-$130.87M-$70.80M-$102.25M-$58.42M-$45.39M-$56.79M-$86.12M-$18.48M-$21.55M
EPS (Diluted)$-3.17$-2.32$-1.82$-2.74$-2.03$-0.52$-0.68
Total Assets$364.00M$418.46M$355.18M$180.36M$263.37M$91.72M$72.97M$78.17M$18.68M$31.62M
Total Liabilities$57.88M$81.96M$88.86M$83.99M$78.99M$73.18M$64.64M$40.53M$5.34M$10.74M
Shareholders' Equity$306.11M$336.50M$266.32M$96.37M$184.38M$18.54M$8.33M$37.63M$13.34M$20.88M
Cash & Equivalents$101.82M$99.70M$281.26M$95.63M$178.59M$44.91M$22.21M$45.26M$16.90M$15.31M
Operating Cash Flow-$240.11M-$126.23M$1.88M-$65.00M-$50.10M-$14.44M-$56.70M-$21.91M-$20.49M-$16.32M
Capital Expenditures$3.28M$4.05M$3.48M$2.15M$156.0K$362.0K$213.0K$108.0K$147.0K$113.0K
Shares Outstanding82.83M68.27M49.04M34.08M33.91M18.14M10.94M95.37M39.36M34.17M